Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
The 2027-2032 World Outlook for Myasthenia Gravis
US$ 1,195.00
This study covers the world outlook for myasthenia gravis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Myasthenia Gravis Drugs
US$ 1,195.00
This study covers the world outlook for myasthenia gravis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Myasthenia Gravis Treatments
US$ 1,195.00
This study covers the world outlook for myasthenia gravis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Narcolepsy Drugs
US$ 1,195.00
This study covers the world outlook for narcolepsy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Nasal Polyps Treatments
US$ 1,195.00
This study covers the world outlook for nasal polyps treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Nasal Sprays
US$ 1,195.00
This study covers the world outlook for nasal sprays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Natural Superdisintegrants
US$ 1,195.00
This study covers the world outlook for natural superdisintegrants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
287 pages
The 2027-2032 World Outlook for Neonatal Jaundice Treatments
US$ 1,195.00
This study covers the world outlook for neonatal jaundice treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Neurodegenerative Diseases
US$ 1,195.00
This study covers the world outlook for neurodegenerative diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
288 pages
The 2027-2032 World Outlook for Neurodegenerative Disorders
US$ 1,195.00
This study covers the world outlook for neurodegenerative disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Neurological Disorder Drugs
US$ 1,195.00
This study covers the world outlook for neurological disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Neuropathic Pain Management
US$ 1,195.00
This study covers the world outlook for neuropathic pain management across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Neuroprotection Therapeutics
US$ 1,195.00
This study covers the world outlook for neuroprotection therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Neuroprotective Agents
US$ 1,195.00
This study covers the world outlook for neuroprotective agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Non-Opioid Pain Patches
US$ 1,195.00
This study covers the world outlook for non-opioid pain patches across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Non-Opioid Pain Treatments
US$ 1,195.00
This study covers the world outlook for non-opioid pain treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
288 pages
The 2027-2032 World Outlook for Norovirus Vaccines
US$ 1,195.00
This study covers the world outlook for norovirus vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Nutraceutical Excipients
US$ 1,195.00
This study covers the world outlook for nutraceutical excipients across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Omeprazole
US$ 1,195.00
This study covers the world outlook for omeprazole across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the c...
January 2026
287 pages
The 2027-2032 World Outlook for Opioid Drugs
US$ 1,195.00
This study covers the world outlook for opioid drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Opioid Use Disorders
US$ 1,195.00
This study covers the world outlook for opioid use disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Oral Alopecia Drugs
US$ 1,195.00
This study covers the world outlook for oral alopecia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Oral Anti Diabetes Drugs
US$ 1,195.00
This study covers the world outlook for oral anti diabetes drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Oral Compounding Pharmacies
US$ 1,195.00
This study covers the world outlook for oral compounding pharmacies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Oral Iron Drugs
US$ 1,195.00
This study covers the world outlook for oral iron drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Oral Proteins and Peptides
US$ 1,195.00
This study covers the world outlook for oral proteins and peptides across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
287 pages
